BRIEF-Eleven Biotherapeutics Reports Q4 Loss Per Share $0.22 By: Reuters: Company News April 04, 2018 at 16:25 PM EDT * ELEVEN BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 OPERATING RESULTS AND VICINIUM DEVELOPMENT PROGRESS Read More >>